Pharmacocorrection of mitochondrial dysfunction and energy imbalance of substantia nigra neurons in experimental Parkinson's disease in rats
<p>Parkinson's disease (PD) is a progressive disease and the incidence increases markedly with age, treatment has significantly improved the quality of life of patients with PD, but statistics show that these patients continue to show shorter life expectancies compared to the general popu...
Main Author: | Volodymyr Maramukha |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2020-11-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/32001 |
Similar Items
-
Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
by: Olga Buneeva, et al.
Published: (2020-12-01) -
Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
by: Steven M. Graves, et al.
Published: (2021-08-01) -
Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
by: Sarah Plum, et al.
Published: (2020-12-01) -
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
by: Andrea Mancini, et al.
Published: (2020-07-01) -
MOLECULAR MARKERS OF ENDOGENOUS NEUROPROTECTION IN THE BRAIN OF RATS WITH EXPERIMENTAL PARKINSON'S DISEASE AND ON THE BACKGROUND OF USING NEW PHARMACOTHERAPY SCHEMES
by: Volodymyr Maramukha
Published: (2020-10-01)